Two private equity firms, EW Healthcare Partners and Hayfin Capital, completed a $100m investment in MiMedx, a biomedical company. “This transaction marks the culmination of an extensive review of potential financing alternatives by the Board, in consultation with the company’s advisors, which included a leading investment bank with in-depth, industry-specific expertise. A new leadership team, new board members, and now the opportunity to welcome these accomplished and well-regarded leaders to our Board of Directors, each demonstrate great progress toward transforming and positioning the company for the future,” M. Kathleen Behrens, MiMedx Chair of the Board of Directors.